Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Bone scan

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  4  5  6  Next»
    Study title: Guillet J, Guillet C, Blanquet P. [Radionuclide assessment of skeletal growth and maturation (160 bone scans in patients aged 0 to 21 years) (author's transl)] Ann Pediatr (Paris). 1982 Mar;29(3):189-92. French. No abstract available. Guillet J, Guillet C, Blanquet P. [Radionuclide assessment of skeletal growth and maturation (160 bone scans in patients aged 0 to 21 years) (author's transl)] Ann Pediatr (Paris). 1982 Mar;29(3):189-92. French. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44092
    Study title: Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available. Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44040
    Study title: Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6. Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43409
    Study title: Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43610
    Study title: Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32. Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44089
    Study title: Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available. Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43615
    Study title: Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French. Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43920
    Study title: Comparison of bone scan and radiograph sensitivity in the detection of steroid-induced ischemic necrosis of bone. Conklin JJ, Alderson PO, Zizic TM, Hungerford DS, Densereaux JY, Gober A, Wagner HN. Radiology. 1983 Apr;147(1):221-6.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44043
    Study title: Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43839
    Study title: Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available. Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43625
    Study title: Bilateral accessory iliac horns: pathognomonic findings in Nail-patella syndrome. Scintigraphic evidence on bone scan. Goshen E, Schwartz A, Zilka LR, Zwas ST. Clin Nucl Med. 2000 Jun;25(6):476-7.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43483
    Study title: The role of bone scan in the diagnosis of Jaffé-Lichtenstein-Uehlinger syndrome. Chroustova D, Votruba M, Sprindrich J, Sosna B. Nucl Med Rev Cent East Eur. 2004;7(1):87-9.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43398
    Study title: Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44078
    Study title: Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med. 1987 Dec;28(12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48839
    Study title: Bone scans in neuroblastoma.Bhogate BM, Samuel AM, Ramanathan P. Indian J Cancer 1993 Mar;30(1):5-9.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48571
    Study title: Potentially misleading bone scan findings in patients with hepatoblastoma.Archer D, Babyn P, Gilday D, Greenberg MA. Clin Nucl Med 1993 Dec;18(12):1026-31
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48529
    Study title: Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71. Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43444
    Study title: Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy.Laxer RM. Allen RC. Malleson PN. Morrison RT. Petty RE. J Pediatr 1985Mar;106(3):437-40
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48496
    Study title: The bone scan in desseminated BCGitis.Alavi M, Safavi S. Hell J Nucl Med 2008;11(1):46-7.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48526
    Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48759
    1  2  3  4  5  6  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Feb 12 06:16:54 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA